Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020)
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index; 1 of the 8 sources its claims cite were checked for support.
Abstract
The systemic immunity-inflammation index (SII) is a novel inflammatory marker, and aberrant blood lipid levels are linked to inflammation. This study aimed to look at the probable link between SII and hyperlipidemia. The current cross-sectional investigation was carried out among people with complete SII and hyperlipidemia data from the 2015–2020 National Health and Nutrition Examination Survey (NHANES). SII was computed by dividing the platelet count × the neutrophil count/the lymphocyte count. The National Cholesterol Education Program standards were used to define hyperlipidemia. The nonlinear association between SII and hyperlipidemia was described using fitted smoothing curves and threshold effect analyses. A total of 6117 US adults were included in our study. A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis. Age, sex, body mass index, smoking status, hypertension, and diabetes were not significantly correlated with this positive connection, according to subgroup analysis and interaction testing (p for interaction > 0.05). Additionally, we discovered a non-linear association between SII and hyperlipidemia with an inflection point of 479.15 using a two-segment linear regression model. Our findings suggest a significant association between SII levels and hyperlipidemia. More large-scale prospective studies are needed to investigate the role of SII in hyperlipidemia.
Overview
CoChat Summary
TL;DR
In a cross-sectional NHANES 2015–2020 sample of 6,117 US adults, higher systemic immunity-inflammation index (SII) was associated with higher odds of hyperlipidemia in minimally and partially adjusted models. The association was nonlinear, with an inflection point at SII 479.15, and became statistically insignificant in the fully adjusted model.
Key findings
- Among 6,117 participants, mean SII was 459.54 ± 317.28, mean age was 50.70 ± 17.43 years, 48.08% were male, and 69.72% had hyperlipidemia.
- SII/100 was positively associated with hyperlipidemia in model 1 [OR 1.04 (1.02, 1.06)] and model 2 [OR 1.03 (1.01, 1.05)], but not in fully adjusted model 3 [OR 1.02 (1.00, 1.04)].
- In SII quartile sensitivity analysis using model 2, Quartile 4 was associated with a 27.04% increased risk of hyperlipidemia versus Quartile 1 (p for trend < 0.05).
- A nonlinear association was found with an inflection point of 479.15; in women, an inverted U-shaped curve had an inflection point of 958.14. Subgroup interaction tests were not significant (p for interaction > 0.05).
Methods
- Cross-sectional study using NHANES 2015–2020 data; from 25,531 eligible people, exclusions for missing SII data (5,264), missing hyperlipidemia data (12,969), and age <20 years (1,181) yielded 6,117 participants.
- SII was calculated as platelet count × neutrophil count / lymphocyte count; hyperlipidemia was defined by NCEP ATP III criteria or reported use of cholesterol-lowering drugs.
- Multivariable logistic regression with three adjustment models, smooth curve fitting, threshold effect analysis, and subgroup/interaction testing; analyses used R and EmpowerStats with weighting.
Limitations
- The authors state that the cross-sectional design cannot establish causation and that prospective studies are needed.
- The authors state that residual confounding may remain, including long-term medication use such as steroids, which was not recorded in NHANES; they also note that the inflammation–disease interaction is complex and generalization may be improper.
- Evident from the text: the fully adjusted model 3 did not retain statistical significance, and the abstract describes “multivariate linear regression” while the Methods/Results describe multivariable logistic regression.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 3 Not checked · 21 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This association was significant both in model 1 (1.04 (1.02, 1.06)) and model 2 (1.03 (1.01, 1.05)).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SII was shown to correlate significantly with hyperlipidemia in subgroups stratified by sex, BMI, and diabetes (p < 0.05).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction tests revealed that the relationship between SII and hyperlipidemia was not statistically different across strata, showing that age, sex, BMI, smoking status, hypertension, and diabetes did not significantly impact this positive correlation (p for interaction> 0.05).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, in model 3, the positive association between SII and hyperlipidemia became insignificant (1.02 (1.00, 1.04)).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This association was significant both in model 1 (1.04 (1.02, 1.06)) and model 2 (1.03 (1.01, 1.05)).”
- Also stated in: § Abstract · plain
“A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an associationn = 6,117 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
8 more claims
Create a free account to see all 25 claims and to verify the 7 references still open.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 6
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To minimize the influence of highly variable MHR values, MHR was scaled by multiplying by 10 (19).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.3. SII and Covariates
“The systemic immunity-inflammation index is the dependent variable in this investigation.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.3. SII and Covariates
“SII was intended as an exposure variable in our research.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > Abstract
“A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.4. Statistical Analysis
“To examine the association between SII and hyperlipidemia, multivariate logistic regression analysis between SII and hyperlipidemia was used”
Citations
Cites
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · cited 1×
“Adult Treatment Panel III (ATP 3) of the National Cholesterol Education Program (NCEP) classified hyperlipidemia as total cholesterol 200 mg/dL, triglycerides 150 mg/dL, HDL 40 mg/dL in males and 50 mg/dL in females, or low-density lipoprotein 130 mg/dL [21].”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · cited 1×
“In the United States, 28 million people had total cholesterol levels higher than 240 mg/dL [4].”
BackgroundHeart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797 · cited 1×
“In addition, hyperlipidemia significantly increases the risk of cardiovascular and immune diseases and is a significant cause of stroke and death [5].”
BackgroundTarver, T. (2014) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,605
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412 · cited 1×
“described infantile-onset STING-associated vasculopathy caused by a systemic gain-of-function mutation in the TMEM173 gene and in patients characterized by systemic inflammation [37,38].”
BackgroundSelf-citationResolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“The ability of SPM to limit leukocyte infiltration and counter-regulate the production of pro-inflammatory mediators is one of its main biological functions [44].”
BackgroundInflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184 · cited 1×
“The interaction between systemic inflammation and the local immune response has been identified as the seventh cancer hallmark, and it has been shown to be involved in the initiation, development, and progression of various forms of cancer [11,12].”
Background
Cited by
Items 201–277 of 277
Zheng, X., Zhang, J. Y., & Xiao, Z. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4827651
Association between pan-immune-inflammation value and hyperlipidemia in the United States populationPreprint
Yan, Y., Jia, S., Huo, X., Liu, L., Ma, S., & Chen, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4662107/v1
Li, J., Tang, M., Deng, Z., Feng, Y., Dang, X., Sun, L., Zhang, Y., Yao, J., Zhao, M., & Liu, F. (2024) · medRxiv · doi:10.1101/2024.09.07.24313248
Peng, J., & Chen, H. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.09.012
Gao, L., Xu, F., Zhen, S., & Cai, Y. (2024) · International Journal of Women s Health · doi:10.2147/ijwh.s492712
Xiang, F., Mao, H.-X., Xu, Y., & Ge, X.-X. (2025) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v33.i2.122
“烟定义为从不吸烟 [11] .”
Wen, H., Su, B., Liu, J., & Wang, H. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1511112
Li, J., Qin, Q., Zhu, Y., Qian, Y., Yin, J., Gao, X., Wen, H., & Wang, P. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70424
RetractedWu, P., Huang, Z., Ma, J., Zhu, B., Wang, M., Ma, A., Wang, X., Hai, R., Jia, S., Ma, X., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6611872/v1
Wang, X. (2025) · Research Review · doi:10.52845/cs/2025-5-3-67
AlSudais, H., Alfhili, M. A., & Almuqrin, A. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00375-3
“SII has been associated with hyperlipidemia in the U.S. population and with diabetic kidney disease in Chinese patients with type 2 diabetes [15] [16], while elevated SIRI has been linked to increased cardiovascular mortality in large cohorts [17].”
Luo, K., Duan, L., He, H., Hu, X., Pi, K., Yu, J., Yang, Y., Xia, W., Dai, M., Liao, C., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119184 · Cited by 1
Chai, Y., Wang, G., Zhu, S., Wei, C., Du, R., Liu, Z., Zhao, S., Yang, L., & Geng, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.70983
Rheeman, M. J., Rothschild, M. I., Pokabla, M. J., Adam, A. P., & Wladis, E. J. (2025) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000003127
Tao, H., Chen, S., Zeng, W., You, L., Xu, J., Saw, P. E., Li, Y., & Ren, M. (2025) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2025.10.016 · Cited by 1
Microbiota-supportive diets and hyperlipidemia: The mediating role of systemic inflammation
Wang, W., & Jiang, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0337398 · Cited by 1
“Hyperlipidemia was classified based on clinical thresholds consistent with national guidelines and prior NHANES research [18,19].”
Nie, Y., He, Z., Liu, B., Li, J., Liu, Y., Su, X., Yan, Z., Li, Z., Yan, C., Lu, Q., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1698225
Self-citationYuyang, C. (2025) · European Journal of Pain · doi:10.1002/ejp.70179
“Notably, a U-shaped association has been observed between SII and hyperlipidemia risk, with an inflection point at 479.15 (Mahemuti et al. 2023).”
InfluentialAging and Frailty: From Causes to Prevention
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-7176-7
Hang, L., Zhou, J., Luo, Z., & Zhang, L. (2025) · Medicine · doi:10.1097/md.0000000000046397
“Upon identification of a nonlinear relationship, a 2-piecewise linear regression model was constructed, [18] employing the obtained smoothing plot to quantify the threshold impact of the Log NHR on the 28-day mortality rate.”
Zeng, Y., Zhang, K., & Wu, X. (2025) · Medicine · doi:10.1097/md.0000000000046673
“[10] Due to the skewness observed in the distribution of SII, a natural logarithmic (LN) transformation was employed to approximate a normal distribution.”
Jin, N., Huang, L., Hong, J., Zhao, X., Hu, J., Wang, S., Chen, X., Rong, J., & Lu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26653807
Shen, T., Zheng, Q., Zhong, L., Zeng, X., Yuan, X., Mo, F., Zhu, S., Yang, W., & Chen, Q. (2024) · Figshare · doi:10.6084/m9.figshare.24940560
Liu, J., Wang, H., Liu, Q., Long, S., Wu, Y., Wang, N., Lin, W., Chen, G., Lin, M., & Wen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26703286
La, R., Yin, Y., Ding, W., He, Z., Lu, L., Xu, B., Jiang, D., Huang, L., Jiang, J., Zhou, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25909969
Jin, N., Huang, L., Hong, J., Zhao, X., Hu, J., Wang, S., Chen, X., Rong, J., & Lu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24820005
Chaoqun, L., Zhang, C., Song, J., Yan, L., Xiao, Y. H., Cheng, N., Wu, H., Chen, X., & Yang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26730694
Chaoqun, L., Zhang, C., Song, J., Yan, L., Xiao, Y., Cheng, N., Wu, H., Chen, X., & Yang, J. (2024) · Figshare · doi:10.6084/m9.figshare.25989198
Liu, J., Wang, H., Liu, Q., Long, S., Wu, Y., Wang, N., Lin, W., Chen, G., Lin, M., & Wen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26703289
Jin, N., Huang, L., Hong, J., Zhao, X., Hu, J., Wang, S., Chen, X., Rong, J., & Lu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26653810
Liu, J., Li, J., Xia, C., He, W., Li, X., Shen, S., Zhou, X., Tong, N., & Peng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26700817
Xie, F., Yu, Z., Xiong, Y., Wu, Z., & Wu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26685609
Chaoqun, L., Zhang, C., Song, J., Yan, L., Xiao, Y. H., Cheng, N., Wu, H., Chen, X., & Yang, J. (2024) · Figshare · doi:10.6084/m9.figshare.25989357
Zeng, P., Jiang, C. S., Liu, A., Yang, X., Lin, F., & Cheng, L. (2024) · Figshare · doi:10.6084/m9.figshare.25001694
Jin, N., Huang, L., Hong, J., Zhao, X., Hu, J., Wang, S., Chen, X., Rong, J., & Lu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24819566
Liu, J., Wang, H., Liu, Q., Long, S., Wu, Y., Wang, N., Lin, W., Chen, G., Lin, M., & Wen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26703283
Body roundness index and rheumatoid arthritis risk: Evidence from NHANES 1999 to 2020
Huang, X., Huang, W., Li, J., & Peng, C. (2025) · Medicine · doi:10.1097/md.0000000000046618
“[16] This study utilized publicly available NHANES datasets, which were collected in accordance with ethical guidelines, with informed consent obtained from all participants.”
Peng, L., Wang, J., Gao, C., Yang, Y., Duan, X., Mou, K., & Li, P. (2026) · British Journal Of Nutrition · doi:10.1017/s0007114525106107
“Hypertension was diagnosed in respondents meeting any one of the following criteria: (1) Mean systolic/diastolic blood pressure > 140/90 mmHg during physical examination; (2) self-reported history of hypertension diagnosis and (3) self-reported current use of antihypertensive medication (27) .”
Chen, Y., Yu, S., Nan, W., Cai, X., & Peng, Z. (2026) · Environmental Sciences Europe · doi:10.1186/s12302-025-01302-7
Zou, Y., Peng, J., Peishuang, L. I., Xu, L., Peng, X., & Liang, R. (2026) · Medicine · doi:10.1097/md.0000000000046939
“[12] This study utilized publicly available NHANES datasets, which were collected in accordance with ethical guidelines, with informed consent obtained from all participants.”
Ma, F., Cong, Z.-C., Zhang, H., Chen, Y.-H., Cui, Y.-L., Duan, Y., & Tao, T. (2026) · Journal of International Medical Research · doi:10.1177/03000605261419655
Ye, L., Yu, F., Li, Z., Tan, B., Wang, H., Wang, Y., Li, Q., Zhou, S., Chen, Z., Zong, G., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121500
ВЛИЯНИЕ ГИПЕРУРИКЕМИИ НА ПОКАЗАТЕЛИ ЛИПИДНОГО ПРОФИЛЯ У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ ФОРМОЙ ИБС
Куприянова, А. А., Сергеева, О. С., & Шевцова, В. И. (2024) · Смоленский медицинский альманах · doi:10.37903/sma.2024.2.46
Liu, Y., Wang, Y., Wang, R., Yang, Q., Pan, G., & Zhang, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1738104
Self-citationLiu, G., Wang, X., Wang, X., 周海斌, & Shen, G. (2026) · medRxiv · doi:10.64898/2026.03.12.26348264
Chen, Y., Zhang, Y., Huang, X., Luo, X., & Wang, H. (2026) · Dermatologic Therapy · doi:10.1155/dth/9878608
Wang, Y., Li, Z., Zhang, S., Zhang, D., He, Z., Tang, G., Wang, Z., Zhu, X., & Zheng, Q. (2026) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-026-04298-y
Zhuang, Y., Liu, X. Y., Huang, Y., Lin, C., Li, Y., Huang, Y., Wang, Y., & Liu, X. (2026) · Science Progress · doi:10.1177/00368504261444470
A Rare Case Report of Immunoglobulin D Subtype Multiple Myeloma Complicated With Hyperlipidemia
Yang, L., Zhou, Z., Qu, X., Jing, L., Liu, J., Chen, L., & Ma, L. (2026) · Case Reports in Hematology · doi:10.1155/crh/9065226
“It is well known that renal impairment and in-fammation may be involved in the pathogenesis of hyperlipidemia [7, 8].”
Duan, Y., Su, Y., Peng, Y., & Chen, A. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s527740
“7,8 Research suggests that in hyperlipidemia, fat tissue releases large amounts of pro-inflammatory factors such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), leading to long-term low-grade inflammation.”
Hua, Y., Wu, Z., Li, Y., Pan, Y., Xin, X., Zhou, S., Zhao, S., Fan, Y., Wen, C., Ji, J., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158237
Wang, R., Liu, D., Xu, Z., Lou, L., Qu, K., & Yang, H. (2026) · Medicine · doi:10.1097/md.0000000000048552
“10–12] This establishes a metabolic microenvironment conducive to IR and β -cell impairment, thereby contributing to the pathogenesis of T2DM.”
Zhou, Y., Zhu, Y., Li, S., He, Z., Zhang, Y., Wang, Z., He, C., Zhu, H., Li, N., Li, J., et al. (2026) · Helicobacter · doi:10.1111/hel.70135
“27 [42–47], In this context, the suppression of gastric GPIHBP1 observed in our study may reflect a broader infection-associated endothelial response rather than a purely localized phenomenon.”
Al-Essa, Y. M., Aljumah, H. K., saeed, Z. Y. A., AlQattan, R. A., Alquwayzani, D., Al-Yousef, G. K., owdah, A. S. A., Alzuwayr, M. A., & Elsheikh, E. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1859225
“…based on routine complete blood count parameters, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and systemic immune-inflammation index (SII), are markers of systemic inflammation and cardiometabolic risk (12 – 18).”
Alhalwani, A. Y., Altasan, A., Alasmari, N. A., Almutiri, A., Sünbül, M., Khalifa, R., Makhtoum, J., & Jambi, S. (2026) · Frontiers in Ophthalmology · doi:10.3389/fopht.2026.1762122
Sun, M., Li, Z., Zhou, Z., Chen, J., & Wei, J. (2026) · International Journal of Hypertension · doi:10.1155/ijhy/9214764
Self-citationLi, Y., Li, Y., Li, X., Zhu, P., & Zhou, M. (2026) · Medicine · doi:10.1097/md.0000000000049311
“[7] 16] However, the predictive value of the SII and PLR in assessing the risk of breast cancer remains unclear.”
Zhang, Q., Jia, Z., Hou, H., & Yang, X. (2026) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303430103251204120642
Wan, J., Li, Y., Huang, Y., Yu, L., Liu, L., & Yang, B. (2026) · Current Therapeutic Research · doi:10.1016/j.curtheres.2026.100840
Zeng, J., Liu, X., Huang, Y., Huang, Y. Q., Wang, Y., & Liu, X. (2026) · Medicine · doi:10.1097/md.0000000000049649
“…tri-glycerides ≥150 mg/dL; or dyslipidemia, defined as total cholesterol ≥200 mg/dL, LDL cholesterol ≥130 mg/dL, or HDL cholesterol <40 mg/dL. [19] Participants were considered diabetic if they reported a physician diagnosis, had an HbA1c ≥6.5 %, showed a fasting plasma glucose ≥7.0 mmol/L,…”
InfluentialZeng, C., Huang, W., Zhou, P., Chen, M., Yuan, X., Li, Z., Feng, X., Yang, L., Zhao, X., & Yan, Q. (2026) · Toxicology Research · doi:10.1093/toxres/tfag048
Feng, R., Shao, Y., Zhao, Y., Cui, X., Jiao, C., & Zhou, H. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2697130
“Furthermore, common comorbidities such as hypertension [36], hyperlipidemia [37], diabetes [38], coronary heart disease [39], heart failure [40], hepatitis B [41], and thyroid disorders [42] can independently influence inflammatory indices, thereby attenuating their specificity for kidney-related…”
Wang, C., Yu, S., & Chen, T. D. (2026) · Medicine · doi:10.1097/md.0000000000049970
Research Progress of Systemic Inflammatory Indices in the Assessment of Coronary Atherosclerosis
高, 增. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1672761
Zhao, Q., Peng, L., & Li, L. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1840437
“Compared with a single inflammatory parameter, SII integrates multiple inflammatory and thrombosis-related factors and is considered a relatively stable indicator for evaluating the intensity of systemic inflammatory responses (6).”
Tu, B., Zhu, S., Hu, P., Zhu, X., Wang, J., Liu, X., Fu, S., Wang, T., Liu, J., & Cui, K. (2026) · Andrology · doi:10.1111/andr.70370
Liao, Y., Duan, S., Ye, S., Li, Z., Hong, Y., Li, Y., Zheng, R., Tang, Z., Lei, N., Zhao, Y., et al. (2026) · Discover Food · doi:10.1007/s44187-026-01161-y
“[35, 36].”
Cheng, X.-C., Mu, L.-Y., Wang, Z., Li, H., Qu, X.-Q., Liu, D., Li, S., Peng, B.-Q., Qiu, P., Jiang, Z.-Y., et al. (2026) · Calcified Tissue International · doi:10.1007/s00223-026-01604-9
Wang, Y., Huang, Y., Lin, C., Chen, X., Li, Y., Huang, Y., & Liu, X. (2026) · Medicine · doi:10.1097/md.0000000000050849
“…≥150 mg/dL, total cholesterol ≥200 mg/dL, low-density lipoprotein cholesterol ≥130 mg/dL, or high-density lipoprotein cholesterol 40 mg/dL. [20] Diabetes was defined as a physician diagnosis, glycated hemoglobin ≥6.5%, fasting plasma glucose ≥7.0 mmol/L, a 2-hour oral glucose tolerance…”
InfluentialXu, S., Huang, J., Hu, L., Li, X., Shumin, Z., Chen, K., & Chen, L. (2026) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.26-00088
“Persistent systemic in fl ammation may interfere with insulin signaling, promote insulin resistance and dyslipidemia, and impair the anti-in fl ammatory and cholesterol-transport functions of lipoproteins [40, 41].”
Zheng, Y., Guo, Z., Zhao, L., Peng, X., Zhu, Y., Shan, G., Li, T., & Li, X. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70576
“Existing evidence has indicated the associations between these inflammatory indices and NCDs such as cognitive decline [25], CVD [26], ischemic stroke [27], hyperlipidemia [28], and gastric cancer [29].”
Jiang, Z., Huang, L., Xu, J., He, Y., Wang, F., Gui, J., 施达, Cao, S., 郜艳芳, Chen, W., et al. (2026) · Nutrition Research · doi:10.1016/j.nutres.2026.10.013
Lipid-immune interplay in chronic inflammatory-based disorders
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8967-0
Qing, Y., & Chu, Z. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm62005
Metadata
- Authors
- Mahemuti, N., Jing, X., Zhang, N., Liu, C., Li, C., Cui, Z., Liu, Y., & Chen, J.
- Affiliations
- Tianjin Medical University (CN)
- Tianjin Huanhu Hospital (CN)
- Corresponding author
- Chen, Jiageng
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-02-26
- Volume
- 15
- Issue
- 5
- Pages
- 1177
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10004774
- OpenAlex
- W4322503120
- Cited by
- 260
- References
- 52
- Citations by year
- 2026: 37 · 2025: 104 · 2024: 105 · 2023: 14
- FWCI
- 32.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tianjin Health Research Project (TJWJ2022QN062, 2021KJ255)
- Tianjin Municipal Education Commission (TJWJ2022QN062, 2021KJ255)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- hyperlipidemia, inflammation, inflammatory markers, platelet count, neutrophil-to-lymphocyte ratio, nonlinear relationship, threshold effects, serum lipids, adults
- MeSH terms
- Adult, Cross-Sectional Studies, Humans, Hyperlipidemias, Inflammation, Nutrition Surveys, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.